BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 21, 2018
View Archived Issues
Institut Pasteur de Montevideo and Universidad de la Republica describe new trolox derivatives
Read More
MJFF announces funding for investigator-initiated projects in Parkinson's disease
Read More
Immunicum obtains ATMP certificate from EMA for ilixadencel
Read More
Novel orthoIL-2/IL-2R pairs show efficacy in mouse model of melanoma
Read More
FDA expands approval of Adcetris
Read More
FDA clears Therapix's IND for phase IIa study of THX-110
Read More
Ocugen's phase II study of OCU-310 demonstrates proof-of-concept for dry eye disease
Read More
Antibe Therapeutics' ATB-346 shows better gastrointestinal safety in phase IIb study
Read More
Intranasal octreotide formulation DP-1038 demonstrates viability in healthy volunteers
Read More
KemPharm reports positive topline results from PK study of KP-415
Read More
Curtana Pharmaceuticals describes new Oligo2 inhibitors
Read More
PR-001, a new 5-HT7 inhibitor for the treatment of inflammatory bowel disease
Read More
Novel Bcl-2 inhibitors identified at Centaurus BioPharma
Read More
Zealand reports phase III immunogenicity results for dasiglucagon
Read More
Shanghai Institute Materia Medica discovers bromodomain-containing protein 4 inhibitors
Read More
Biophytis seeks E.U. orphan drug designation for Sarconeos for DMD
Read More
Bristol-Myers Squibb discovers novel indoleamine 2,3-dioxygenase 1 inhibitors
Read More
Idenix Pharmaceuticals, Merck & Co. patent novel tenofovir prodrugs
Read More
Prothena collaborates with Celgene to develop new therapies for neurodegenerative diseases
Read More
Helsinn to acquire worldwide rights to Valchlor/Ledaga
Read More
ON-150030, a novel therapeutic agent to treat acute myeloid leukemia through FLT3 inhibition
Read More
MHRA allows U.K. early access to volanesorsen for familial chylomicronemia syndrome
Read More
Arena reports promising topline results from phase II trial of etrasimod in ulcerative colitis
Read More
Anti-HIV monoclonal antibody VRC07-523LS safe and well-tolerated in phase I study
Read More
First phase II results for GV-1001 in benign prostatic hyperplasia
Read More
FDA approves Ilumya for moderate to severe plaque psoriasis
Read More